Connect with us

Health

Growing Hemp Legalized in This Country

Editor

Published

on

Hemp, a species of cannabis plant, has been valued since ancient times for its fibers and seeds, but it’s been illegal to grow in the U.S. for decades. That all changed in late 2018 with the passage of the 2018 Farm Bill. It included a section legalizing hemp production, paving the way for what many are calling the next big cash crop.

Hemp has many uses, ranging from food to fiber, but it’s also the source of the hemp-derived compound cannabidiol (CBD), which shows promising medical uses. The CBD market in the U.S. was estimated at $600 million in 2018, with projections shooting up over $20 billion by 2022.1

The change in hemp’s legal status was a long time coming and paves the way for this beneficial plant to be treated like other crops, instead of an illegal substance.

The History of Hemp

The legalization of hemp is cause for celebration for more than just hemp supporters, who have been spearheading legalization attempts for decades. The move has ramifications for human health and the environment, now that this plant will no longer be treated as an illicit drug.

Hemp has been valued for thousands of years, with perhaps the oldest discovery of hemp dating back to a piece of hemp fabric from 8,000 B.C.2 As noted by the National Hemp Association, hemp has been used throughout the world for centuries:3

“The spread of cannabis took place from China to the Middle East and the Mediterranean area and, subsequently, to Europe, probably via nomadic peoples. Starting around the year 600, the Germans, Frankish tribes and Vikings produced rope, cloth and garments from hemp fiber.

In the Middle Ages, most people wore hemp sandals. Many farmers grew hemp on a small scale. Since the Middle Ages, the industrial use of hemp has seen a number of peaks.”

In the 17th century, for instance, ships took to the seas with sails and lines made from braided hemp fibers. Hemp clothing was also popular, and Rembrandt used hemp paper for sketching. In the U.S., Presidents Washington and Jefferson grew hemp, and according to the Hemp Industries Association (HIA), “Americans were legally bound to grow hemp during the Colonial Era and Early Republic.”4

By the 19th century, however, alternative materials like cotton and wood pulp began to take hemp’s place, making it less popular. In 1937, the Marijuana Tax Act was passed, which grouped hemp with marijuana, making hemp sales heavily taxed. The financial strain caused may hemp businesses to close and the hemp industry further declined.5

WWII brought with it a brief boost for hemp, with the U.S. Department of Agriculture (USDA) encouraging U.S. farmers to grow the plant and the government offering subsidies for hemp cultivation. About 1 million acres of hemp were planted in the U.S. during that time, and the stiff fiber was used to make parachutes, uniforms, tarps and other products useful to the war industry.

“After the war ended, the government quietly shut down all the hemp processing plants and the industry faded away again,” the HIA noted.6 The final nail in the coffin came with the passage of the Controlled Substances Act of 1970, which grouped hemp and marijuana together as Schedule 1 substances, a classification reserved for drugs with “high potential for abuse” and “no accepted medical use.”

Three years later the Drug Enforcement Agency (DEA) was formed to enforce the newly created drug schedules, and the fight against marijuana and hemp use began.

Marijuana Versus Hemp: What’s the Difference?

While both marijuana and hemp come from the cannabis plant, hemp is low in tetrahydrocannabinol (THC), which is the substance that produces the “high” associated with marijuana use. Whereas hemp typically contains 0.3 percent THC or less, marijuana may contain anywhere from 5 to 35 percent THC, according to HIA.

Interestingly, the 0.3 percent for THC in hemp came about quite by accident when a couple of Canadian scientists designated that number in a 1976 report they wrote on the two plants. Later, the DEA used the same number when they were formulating rules to ban hemp and all products with THC in them. The 0.3 percent later became part of federal law with the 2014 Farm Bill, explained later in this article.7

And while the THC percentage varies in marijuana depending on which part of the plant is used, the Alcohol & Drug Institute at the University of Washington says the average THC in marijuana dried leaves and buds in the U.S. can vary from less than1 percent to 20 percent.8

Marijuana is typically used for medicinal or recreational purposes, whereas hemp can be used for a variety of applications ranging from food and medicine to clothing, construction, body care and even plastic. You can’t get high from hemp, but its high CBD content makes it attractive for medicinal purposes.

Further, whereas marijuana must be grown in a carefully controlled atmosphere, hemp is easy to grow and thrives in most climates. Generally speaking, cannabis sativa, which has long and narrow leaves, is grown outdoors and has higher CBD and low THC, producing no psychoactive effects.

Cannabis idica, on the other hand, has shorter, wider leaves, grows best indoors and contains higher THC, which produces the high most recreational marijuana users are after.

However, because many hybrids have been produced, it’s not possible to identify these qualities from plant name alone.9 According to the 2014 Farm Bill, hemp refers to cannabis sativa plants containing 0.3 percent or less of THC, and that definition remained unchanged in the 2018 Bill.

The Slow Progress Toward Hemp Legalization in the US

In 2013, Colorado legalized industrial hemp farming for commercial and research purposes, provided the farmers verified the THC levels and paid for a permit. In 2014, the Farm Bill also included a section that allowed hemp cultivation for select research and pilot programs, and dozens of states introduced pro-hemp legislation to follow.

By 2017, nearly 26,000 acres of hemp were being grown in 19 states.10 Still, in a major waste of taxpayer dollars, the DEA would target hemp farmers. Ministry of Hemp noted that prior to the 2018 legalization:11

“[F]armers in all these states still risk being raided by the DEA, going to prison, and losing their property because the federal policy fail[ed] to distinguish non-drug oilseed and fiber varieties of industrial hemp from the psychoactive drug varieties (i.e., ‘marijuana’)”

Now that hemp has been legalized, it removes restrictions for crop insurance, banking and other barriers to farmers looking for a profitable crop. Senate Majority Leader Mitch McConnell, who spearheaded the bill, believes hemp could replace tobacco as a new cash crop, stating:12

“At a time when farm income is down and growers are struggling, industrial hemp is a bright spot of agriculture’s future. My provision in the Farm Bill will not only legalize domestic hemp, but it will also allow state departments of agriculture to be responsible for its oversight.”

What’s more, hemp is sometimes described as a miracle crop, providing sustainable material to replace trees for paper, for instance, because it has a growing cycle of just four to six months. Hemp is beneficial for the soil as well, as it doesn’t require the use of pesticides due to its dense, deep roots, which repel weeds naturally.13

Because it grows so close together, hemp can be grown in tight spaces, decreasing land use while still leading to high yields because of its fast growing rate. Basically, hemp grows like a weed, tolerating a variety of climates and soil types, and requiring relatively little water. It was even used to extract toxins from the soil at Chernobyl.14

What Will the Legalization of Hemp Mean for CBD Products?

With hemp’s legalization, CBD products, which are already on the upswing, are set to take off. Their legal status is another issue entirely. CBD is technically illegal according to the DEA, and it’s unclear whether it will be reclassified. The U.S. Food and Drug Administration (FDA), meanwhile, classifies CBD as a drug and has no plans to change that. In a statement, FDA Commissioner Dr. Scott Gottlieb said:15

“[T]he FDA requires a cannabis product (hemp-derived or otherwise) that is marketed with a claim of therapeutic benefit, or with any other disease claim, to be approved by the FDA for its intended use before it may be introduced into interstate commerce. This is the same standard to which we hold any product marketed as a drug for human or animal use.

Cannabis and cannabis-derived products claiming in their marketing and promotional materials that they’re intended for use in the diagnosis, cure, mitigation, treatment or prevention of diseases (such as cancer, Alzheimer’s disease, psychiatric disorders and diabetes) are considered new drugs or new animal drugs and must go through the FDA drug approval process for human or animal use before they are marketed in the U.S.”

CBD can come from either marijuana or hemp. Again, the distinction between these two plants hinges on the THC content. Hemp has very little if any THC, whereas marijuana will have varying amounts of THC. Hemp products such as hemp oil and hemp extract are legal.

So even though they may have small amounts of CBD, hemp products such as hemp oil can be lawfully marketed, provided they don’t reference CBD or claim to cure any diseases. This is a potential loophole the CBD industry could use. The drawback is hemp products may not have much CBD in them, and they may not be clinically effective.

That being said, the new legal status will open up hemp and CBD for research, potentially leading to more definitive knowledge about proper dosing and usage. And as noted by the Ministry of Hemp, “Attitudes are already changing. Even before being signed into law, the 2018 Farm Bill inspired the Alabama state attorney general to back off from plans to prosecute CBD stores.”16

The Many Benefits of Hemp

The hoopla over hemp is well deserved. Its seeds contain nearly as much protein as soybeans and all nine essential amino acids, especially arginine, which is beneficial for heart health.

Two main proteins in hemp seed protein, albumin and edestin, are rich in essential amino acids, with profiles comparable to egg white. Hemp’s edestin content is among the highest of all plants. Hemp protein is also easy to digest because of its lack of oligosaccharides and trypsin inhibitors, which can affect protein absorption.

Hemp seeds are also an excellent source of plant-based omega-3s and include a balanced 1-to-3 ratio of omega-3 and omega-6 fats. Hemp seeds, especially those with the hulls intact, are also rich in fiber and contain a variety of vitamins and minerals, including vitamin E, magnesium, phosphorous, potassium, zinc and B vitamins.

Many of hemp’s health benefits relate to its CBD content as well, which has been found to offer neuroprotective, anti-inflammatory and immunomodulatory benefits.17 Potential uses for CBD and other hemp extracts include:18,19

Medicinal uses aside, hemp seed oil is used in body care products while the fiber can be used to make fabric, clothing, paper and even a recyclable hemp plastic and hemp concrete. There are reportedly more than 25,000 industrial uses for hemp,20 and this probably only scratches the surface of what this versatile plant is good for.

The legalization of hemp in the U.S. will now make it easier for humans and the environment alike to enjoy the benefits of this natural wonder plant once again.

Source link

قالب وردپرس

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health

Post-vaccine surge? Michigan’s spring coronavirus case spike close to previous year’s autumn high

Editor

Published

on

By

(Natural News) The spike in new Wuhan coronavirus infections recorded in Michigan over the spring is similar to a spike seen during the 2020 fall season. According to a Wall Street Journal analysis, the state’s daily coronavirus case count averaged more than 7,000 for almost two weeks – before taking a slight dip to 6,891 on April 20. This echoed similar figures back in November and December 2020, which saw sharp rises in infections for those two months before plunging.

Back in autumn of last year, Michigan averaged more than 7,000 cases per day for a span of 10 days. New infections dropped slightly, then briefly spiked as the December holidays approached. It then fell to the low 1,000s for the succeeding two months – until ascending again in March.

According to University of Michigan internal medicine professor Dr. Vikas Parekh, the sudden increase in new infections could be attributed to several factors. Among the factors he cited was re-openings, which increased people’s interactions and mobility. Parekh said the loosened restrictions contributed to the spread of the highly contagious U.K. B117 variant.

“As the B117 variant spreads nationally, we will likely see other stats [with] their own surges – although I hope none are as bad as Michigan,” the professor remarked. He continued: “The milestone just tells us we are not yet in the clear, especially as we still have large portions of our population who are not vaccinated yet.”

Parekh also expressed optimism over the lower daily caseloads the Great Lakes State reported. He said he believes both cases and hospitalizations have plateaued and will likely decline soon. The professor commented: “[COVID-19] positivity has been declining now for one week, which is usually a leading indicator of case decline.”

Meanwhile, the state cited younger populations and youth sports, such as basketball, wrestling and hockey, to increase new COVID-19 infections. Because of this, Gov. Gretchen Whitmer called to suspend youth sports and indoor dining in the state. She also exhorted high schools to conduct remote class sessions for two weeks to curb the spread of the pathogen.

Michigan still experienced the spike in cases despite having one of the highest vaccination rates in the country

During the opening stages of the U.S.’s immunization drive against COVID-19, Michigan boasted of having one of the highest vaccination rates nationwide. A report by Bridge Michigan even noted the initial “frenzy for vaccines” that “far exceeded the state’s limited supply.” But things have appeared to turn around for Michigan, as it now struggles to reach the 70 percent vaccination rate needed for herd immunity.

Continue Reading

Health

Scottish mom’s legs turn into a pair of “giant blisters” after first dose of AstraZeneca’s coronavirus vaccine

Editor

Published

on

By

(Natural News) Sarah Beuckmann of Glasgow, Scotland, felt a tingling sensation in her legs and noticed a rash flaring up around her ankles a week after getting her first dose of AstraZeneca’s coronavirus (COVID-19) vaccine on March 18.

She also had flu-like symptoms right after the vaccination.

Beuckmann called her doctor to arrange an appointment the morning she noticed the rash, but by the afternoon her skin was already breaking out into blood-filled blisters. Blisters also appeared on her legs, hands, face, arms and bottom.

“I ended up asking my husband to take me to A&E,” said Beuckmann, referring to “accident and emergency,” the equivalent of an emergency room (ER). “When I got there, my heart rate was sitting at 160bpm, which they were very concerned about. I got put on an ECG machine.”

Doctors determine AstraZeneca’s COVID-19 vaccine triggers the rash

Medics carried out tests for HIV, herpes and other skin conditions to work out what triggered the rash, but all results came back negative. Doctors finally determined that the vaccine caused her rare reaction after carrying out two biopsies.

“Once they found that it was a reaction to the vaccine, they put me on steroids and that really seems to be helping my progress,” said Beuckmann. She had been advised by her doctor not to get the second dose of AstraZeneca’s COVID-19 vaccine because of her reaction.

Beuckmann spent 16 days at Queen Elizabeth University Hospital. She was discharged to recover at home. The 34-year-old mother of one is currently wheelchair-bound due to the bandages on her legs and blisters on the soles of her feet. She may need physiotherapy to help strengthen her leg muscles.

“They are starting to heal and they’re looking a lot better than they were but as the blisters started to get worse, they all sort of merged together,” she said. “I didn’t know what was going on.”

With the blisters merging, her legs have looked like a pair of “giant blisters.” Beuckmann admitted that at one point she feared her legs might have to be amputated.

Dermatologist agrees COVID-19 vaccine causes the blisters

Dr. Emma Wedgeworth, a consultant dermatologist and spokeswoman at the British Skin Foundation, agreed that Beuckmann had likely suffered a reaction to the vaccine.

“Vaccines are designed to activate the immune system. Occasionally people will have quite dramatic activation of their immune systems which, as happened in this case, can manifest in their skin” Wedgeworth told MailOnline. “This poor lady had a very severe reaction, which thankfully is extremely rare.”

It is not clear why Beuckmann, who works in retail, was invited for a vaccine. Scotland’s vaccine rollout was focused on people over the age of 50 when she got vaccinated, although vaccines are available to those who are considered at risk from the virus, or live with someone considered vulnerable.

At least 20 million Briton have had AstraZeneca’s COVID-19 vaccine, which drug regulators say causes a rash in one percent of cases. They say rashes caused by the jab tend to go away within a week.

Continue Reading

Health

Trojan labs? Chinese biotech company offers to build COVID testing labs in six states

Editor

Published

on

By

In 2012, BGI acquired Complete Genomics, a DNA sequencing company and equipment maker. The funds for the $117.6 million purchase were raised from Chinese venture capitals. The company has expanded its footprint globally. According to its website, BGI conducts business in more than 100 countries and areas and has 11 offices and labs in the U.S.

People are concerned about China’s access to American DNA data

Some said that with Complete Genomics providing an American base, BGI would have access to more DNA samples from Americans, helping it compile a huge database of genetic information. Some also worried about the protection of the genetic information’s privacy.

According to a 2019 report from the U.S.–China Economic and Security Review Commission (USCC), BGI “has formed numerous partnerships with U.S. healthcare providers and research organizations to provide large-scale genetic sequencing to support medical research efforts,”

There are three main reasons why many people in the biotech community and government have expressed concerns about China’s access to American DNA data.

In the “60 Minutes” interview, Evanina discussed the very likely scenario in which Chinese companies would be able to micro-target American individuals and offer customized preventative solutions based on their DNA.

Evanina asked: “Do we want to have another nation systematically eliminate our healthcare services? Are we okay with that as a nation?”

The second concern is that China may use DNA to track and attack American individuals. As the USCC report states: “China could target vulnerabilities in specific individuals brought to light by genomic data or health records. Individuals targeted in such attacks would likely be strategically identified persons, such as diplomats, politicians, high-ranking federal officials or military leadership.”

The third concern is that China may devise bioweapons to target non-Asians. Steven Mosher, president of the Population Research Institute, discussed it in his article “What Will China Do With Your DNA?” published by The Epoch Times in March 2019.

He wrote: “We know that the Asian genome is genetically distinct from the Caucasian and African in many ways. … Would it be possible to bioengineer a very virulent version of, say, smallpox, that was easily transmitted, fatal to other races, but to which the Chinese enjoyed a natural immunity? … Given our present ability to manipulate genomes, if such a bio-weapon can be imagined, it can probably – given enough time and resources – be realized.”

An article from Technocracy said: “China’s aggressive collection of American DNA should be doubly alarming because it can only spell one ultimate outcome: biowarfare. That is, genetically engineering viruses or other diseases that will be selectively harmful to U.S. populations.”

Continue Reading

Chat

Trending